Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children.
about
PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trialConstipation in Childhood. An update on evaluation and managementReview article: faecal incontinence in children: epidemiology, pathophysiology, clinical evaluation and managementEfficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative.Constipation in children: novel insight into epidemiology, pathophysiology and management.Macrogol 3350 plus electrolytes for chronic constipation in children: a single-centre, open-label study.Pediatric constipation therapy using guidelines and polyethylene glycol 3350.Medical management of constipation.Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover study.Polyethylene glycol 4000 treatment for children with constipation: A randomized comparative multicenter study.Polyethylene glycol 3350 based colon cleaning protocol: 2 d vs 4 d head to head comparisonRandomized, double-blind, placebo-controlled trial of polyethylene glycol (MiraLAX®) for urinary urge symptoms.Medical treatment of constipationPolyethylene glycol 3350 without electrolytes for treatment of childhood constipation.Role of polyethylene glycol in childhood constipation.Managing functional constipation in children.Digital rectal examination and the primary care physicians: a lost art?Childhood constipation: evaluation and management.Use of Powder PEG-3350 as a Sole Bowel Preparation: Clinical Case Series of 245 Patients.Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children.La prise en charge de la constipation fonctionnelle chez l’enfant.Constipation in children
P2860
Q24685783-91511A6A-439F-4A3D-BE76-B28F6E6704F1Q26782240-AEC1A969-24F3-4721-80DF-B6C1B6411F75Q26863670-F0F6771A-9768-4BED-B498-1329BBA61CEAQ34478128-1EDE2392-8102-4406-BD45-12DE7774BC03Q34588759-2777D8E2-33BF-4084-82AB-DBECE46CFB0CQ34652088-0101877C-C4EC-49B1-B712-96264B0D1FA7Q35678263-97B14CEA-F0CA-40E5-A305-5CFBEBA3A651Q35948228-C0E42A28-38D5-402B-B4CF-4F6A60211699Q36154992-C378936A-CF54-4DC8-8FA5-19F6DD18E6EDQ36225131-A5E6940C-2AC6-4CA8-A00C-ECBAD06AEBD2Q36770358-69F8D98D-DC4F-4760-83F8-CB7882D9FF73Q36810583-22A76F81-AC6F-436C-8FF3-362E708C0A8FQ37427645-881C508A-64F7-40E2-97A1-4B658DB73D37Q37480338-B366819B-E955-4E75-8749-DAF94D0994D2Q38151007-51F28681-31BB-4780-B1CC-BE23ABFE5512Q39421514-1335E422-CDC7-4BF0-8BF0-9C18CB05C772Q39764596-FC2E958D-496B-41E0-B8FA-68CE5F6F147CQ41847647-9671803F-5D35-4B90-8D21-ED821F01C3BAQ42039850-C0B29582-BCF6-49C1-9DDA-B816658A97ABQ44012834-A8A9E5FE-FC45-4F7B-81AB-C49CB4886EBEQ45927125-5C7DF8D1-BEC2-4139-AE81-780900D3F4D9Q59270004-E8E9B8AD-7662-43F4-B01F-7A2C82C9B247
P2860
Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Efficacy and optimal dose of d ...... on and encopresis in children.
@en
Efficacy and optimal dose of d ...... on and encopresis in children.
@nl
type
label
Efficacy and optimal dose of d ...... on and encopresis in children.
@en
Efficacy and optimal dose of d ...... on and encopresis in children.
@nl
prefLabel
Efficacy and optimal dose of d ...... on and encopresis in children.
@en
Efficacy and optimal dose of d ...... on and encopresis in children.
@nl
P356
P1476
Efficacy and optimal dose of d ...... ion and encopresis in children
@en
P2093
Pashankar DS
P304
P356
10.1067/MPD.2001.117002
P407
P577
2001-09-01T00:00:00Z